ETON - Eton targets $80M revenue run-rate in Q3 2025 as product launches accelerate
2025-08-08 15:28:30 ET
More on Eton Pharmaceuticals
- Eton Pharmaceuticals, Inc. (ETON) Q2 2025 Earnings Call Transcript
- Eton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With Options
- Eton Pharma Near Term Catalysts Vanish
- Eton gains as hormonal disorder therapy undergoes FDA review
- Eton Pharma wins FDA nod for oral hydrocortisone solution